Kymera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 6.65 M | $314.53 M | 3.99% | 8.73% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 6.00 M | $283.79 M | 0.00% | 7.88% |
| BVF INC/IL | 11/14/2024 | 5.16 M | $244.31 M | 0.00% | 6.78% |
| FMR LLC | 11/13/2024 | 5.11 M | $241.82 M | 5.85% | 6.71% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 4.90 M | $231.75 M | -8.48% | 6.43% |
| VANGUARD GROUP INC | 11/13/2024 | 4.75 M | $225.00 M | -1.42% | 6.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.62 M | $218.59 M | 7.17% | 6.07% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 4.50 M | $212.99 M | 15.71% | 5.91% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.21 M | $199.34 M | 100.00% | 5.53% |
| SIREN, L.L.C. | 11/13/2024 | 2.97 M | $140.56 B | 100.00% | 3.90% |
| STATE STREET CORP | 11/14/2024 | 1.73 M | $81.79 M | -9.55% | 2.27% |
| REDMILE GROUP, LLC | 11/14/2024 | 1.39 M | $65.94 M | -11.78% | 1.83% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.33 M | $62.89 M | 494.73% | 1.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.05 M | $49.86 M | -0.09% | 1.38% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.05 M | $49.67 M | -9.84% | 1.38% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 797,681 | $37.75 M | 85.82% | 1.05% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 600,326 | $28.41 M | -59.98% | 0.79% |
| WOODLINE PARTNERS LP | 11/14/2024 | 525,094 | $24.85 M | 1.41% | 0.69% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 507,902 | $24.04 M | 9.91% | 0.67% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 500,000 | $23.67 M | 100.00% | 0.66% |
| MORGAN STANLEY | 11/14/2024 | 488,077 | $23.10 M | -22.74% | 0.64% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 472,626 | $22.37 M | 17.46% | 0.62% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 453,377 | $21.46 M | 11.71% | 0.60% |
| BOXER CAPITAL, LLC | 11/14/2024 | 450,000 | $21.30 M | 100.00% | 0.59% |
| DEER MANAGEMENT CO. LLC | 11/14/2024 | 415,895 | $19.68 M | 0.00% | 0.55% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 406,348 | $19.23 M | 100.00% | 0.53% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 11/14/2024 | 392,263 | $18.57 M | 100.00% | 0.52% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 366,841 | $17.36 M | -2.20% | 0.48% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 336,300 | $15.92 M | -8.37% | 0.44% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 291,340 | $13.79 M | 122.86% | 0.38% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 270,035 | $12.78 M | -22.61% | 0.35% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 234,771 | $11.11 M | -14.17% | 0.31% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 224,831 | $10.64 M | -51.37% | 0.30% |
| UBS GROUP AG | 11/14/2024 | 217,619 | $10.30 M | 3.48% | 0.29% |
| AQUILO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 208,743 | $9.88 M | -36.50% | 0.27% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 206,894 | $10.07 M | -5.44% | 0.27% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 188,197 | $8.91 M | -36.33% | 0.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 179,186 | $8.48 M | -38.10% | 0.24% |
| INVESCO LTD. | 11/12/2024 | 163,919 | $7.76 M | 449.44% | 0.22% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 143,692 | $7.00 M | -11.41% | 0.19% |
| JPMORGAN CHASE & CO | 11/08/2024 | 140,491 | $6.65 M | 212.59% | 0.18% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 140,187 | $6.64 M | 0.29% | 0.18% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 128,267 | $6.07 M | -1.39% | 0.17% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 124,614 | $5.90 M | 33.04% | 0.16% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 123,045 | $5.82 M | -11.25% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 121,645 | $5.76 M | -22.13% | 0.16% |
| MARSHALL WACE, LLP | 11/14/2024 | 117,681 | $5.57 M | -68.75% | 0.15% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 111,032 | $5.26 M | -26.56% | 0.15% |
| AXA S.A. | 11/14/2024 | 109,312 | $5.17 M | 0.03% | 0.14% |
| ATIKA CAPITAL MANAGEMENT LLC | 11/13/2024 | 97,000 | $4.59 M | 5.43% | 0.13% |
Kymera Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 195 institutional investors and hedge funds held shares of Kymera Therapeutics, Inc.. The most heavily invested institutionals were:
PRICE T ROWE ASSOCIATES INC /MD/: 6.65 M
BAKER BROS. ADVISORS LP: 6 M
BVF INC/IL: 5.16 M
FMR LLC: 5.11 M
Atlas Venture Life Science Advisors, LLC: 4.9 M
VANGUARD GROUP INC: 4.75 M
90.59% of Kymera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.63 M shares in the last 24 months. This purchase volume represents approximately $3.01 B in transactions.